[PTGX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[PTGX] Protagonist Therapeutics, Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 43.78%
YoY- 13.54%
Quarter Report
PTGX's Result
PTGX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 859 25,722 8,617 10,286 2,265 -
PBT -34,194 -31,232 -41,037 -20,930 -36,907 -33,804 -30,842 7.10%
Tax -2,909 -1,071 -406 -181 -832 122 -57 1266.05%
NP -31,285 -30,161 -40,631 -20,749 -36,907 -33,804 -30,842 0.95%
Tax Rate - - - - - - - -
Total Cost 31,285 30,161 41,490 46,471 45,524 44,090 33,107 -3.69%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 -4,730.03 -80.67 -428.30 -328.64 -1,361.68 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.64 -0.62 -0.83 -0.43 -0.77 -0.70 -0.69 -4.87%
EPS Diluted -0.64 -0.61 -0.83 -0.43 -0.77 -0.70 -0.69 -4.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.